Erectile dysfunction and micturition disorders in patients with metabolic syndrome

Introduction. The aetiology and pathogenesis of lower urinary tract symptoms, chronic pelvic pain syndrome, erectile dysfunction are not fully understood. Metabolic syndrome (MS) is an independent factor in these disorders. Purpose the study. To determine significance metabolic development course dysuria, dysfunction. Materials methods. study involved 115 men aged 40 - 60 years. Patients divided into two groups based on presence or absence proven syndrome. age patients main group (n = 86) was 52.0 ± 3.5 A control 29) — without at 50.5 2.4 were questioned using questionnaires IPSS (International System for Summary Assessment Diseases Prostate), ICEF-5 Index Erectile Function). An objective (physical) examination performed. Laboratory diagnostics included determination following indicators: total testosterone, albumin, SHBG (sex hormonebinding globulin), level free testosterone calculated three previous indicators, LH (luteinizing hormone), insulin, glucose, glycosylated haemoglobin, lipid profile. All underwent uroflowmetry, bladder ultrasound residual urine volume, prostate TRUS (transrectal ultrasound) with Doppler blood flow. differences determined by nonparametric Mann-Whitney test; considered statistically significant if probability greater than 95%. Results. MS had more pronounced symptoms scale a QoL index. According to maximum flow rates significantly control. There increase duration urination MS. presented complaints according IIEF5 comparison observation. data obtained make it possible associate risk developing urgency men. Conclusion. acts as hypogonadism, which leads